OTCMKTS PTIX opened at $1.50 on Tuesday. The business has a fifty day moving average price of $1.50. Protagenic Therapeutics has a 12-month low of $1.25 and a 12-month high of $2.50.
Protagenic Therapeutics (OTCMKTS:PTIX) last released its quarterly earnings results on Wednesday, May 15th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter.
Protagenic Therapeutics, Inc, a biotechnology company, engages in the discovery and development of therapeutics to treat central nervous system disorders. Its lead drug candidate is PT00114, which is in clinical proof-of-concept studies for the treatment-resistant depression and/or post-traumatic stress disorder.
Featured Story: What are earnings reports?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Protagenic Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Protagenic Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.